Is CLNNW or QYLD a better dividend investment in 2026?

CLNNW currently yields 111111.11% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CLNNW offers higher current income.

What is the dividend yield difference between CLNNW and QYLD?

CLNNW has a forward dividend yield of 111111.11% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 111099.19 percentage points.

Home › Compare › CLNNW vs QYLD

CLNNW vs QYLD: Dividend Comparison 2026

CLNNW yields 111111.11% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLNNW wins by $1.3838190899465547e+27M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLNNW

● Live price

111111.11%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.3838190899465547e+27M

Annual income

$1,381,373,456,343,941,000,000,000,000,000,000.00

Full CLNNW calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CLNNW vs QYLD

📍 CLNNW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLNNW	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLNNW + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLNNW pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLNNW

Annual income on $10K today (after 15% tax)

$9,444,444.44/yr

After 10yr DRIP, annual income (after tax)

$1,174,167,437,892,349,800,000,000,000,000,000.00/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CLNNW beats the other by $1,174,167,437,892,349,800,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLNNW + QYLD for your $10,000?

CLNNW: 50%QYLD: 50%

100% QYLD50/50100% CLNNW

Portfolio after 10yr

$6.919095449732774e+26M

Annual income

$690,686,728,171,970,500,000,000,000,000,000.00/yr

Blended yield

99.82%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLNNW buys

QYLD buys

No recent congressional trades found for CLNNW or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLNNWQYLD

Forward yield	111111.11% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.3838190899465547e+27M	$25.4K ✓
Annual income after 10y	$1,381,373,456,343,941,000,000,000,000,000,000.00 ✓	$5,659.31
Total dividends collected	$1.383658847866035e+27M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CLNNW vs QYLD ($10,000, DRIP)

Year	CLNNW Portfolio	CLNNW Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$11,121,811	$11,111,111.11	$10,352	$1,192.36	+$11.11M → CLNNW
2	$11,561,029,218	$11,549,128,879.66	$10,830	$1,347.57	+$11561.02M → CLNNW
3	$11,232,204,364,934	$11,219,834,063,671.13	$11,460	$1,539.07	+$11232204.35M → CLNNW
4	$10,199,601,320,781,262	$10,187,582,862,110,782.00	$12,275	$1,777.84	+$10199601320.77M → CLNNW
5	$8,656,721,364,988,387,000	$8,645,807,791,575,153,000.00	$13,323	$2,078.95	+$8656721364988.37M → CLNNW
6	$6,867,176,795,058,000,000,000	$6,857,914,103,197,462,000,000.00	$14,667	$2,463.34	+$6867176795058000.00M → CLNNW
7	$5,091,669,942,459,710,000,000,000	$5,084,322,063,288,997,000,000,000.00	$16,396	$2,960.57	+$5091669942459709440.00M → CLNNW
8	$3,528,599,356,203,225,300,000,000,000	$3,523,151,269,364,793,600,000,000,000.00	$18,631	$3,612.97	+$3.5285993562032256e+21M → CLNNW
9	$2,285,638,880,947,370,600,000,000,000,000	$2,281,863,279,636,233,000,000,000,000,000.00	$21,548	$4,482.15	+$2.2856388809473705e+24M → CLNNW
10	$1,383,819,089,946,554,900,000,000,000,000,000	$1,381,373,456,343,941,000,000,000,000,000,000.00	$25,398	$5,659.31	+$1.3838190899465547e+27M → CLNNW

CLNNW vs QYLD: Complete Analysis 2026

CLNNW — Stock

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Full CLNNW Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CLNNW vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLNNW vs SCHD CLNNW vs JEPI CLNNW vs O CLNNW vs KO CLNNW vs MAIN CLNNW vs XYLD CLNNW vs JEPQ CLNNW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.